Dingdang Health Technology Group Ltd. (HKG:9886)

HKG:9886 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,124	1,402	660	2,670	15,615	-
Market Cap Growth	75.65%	112.50%	-75.29%	-82.90%	-	-
Enterprise Value	238	222	-595	1,085	19,893	-
Last Close Price	0.87	1.07	0.50	1.99	11.64	-
Forward PE	25.61	48.08	-	-	-	-
PS Ratio	0.21	0.26	0.13	0.50	3.19	-
PB Ratio	0.60	0.75	0.37	1.19	6.28	-
P/TBV Ratio	0.65	0.82	0.41	1.47	7.85	-
P/FCF Ratio	9.99	12.46	-	-	-	-
P/OCF Ratio	7.38	9.21	-	-	-	-
EV/Sales Ratio	0.04	0.04	-	0.20	4.07	-
EV/FCF Ratio	2.12	1.97	-	-	-	-
Debt / Equity Ratio	0.17	0.17	0.09	0.07	0.07	-1.86
Debt / EBITDA Ratio	3.23	3.23	-	-	-	-
Debt / FCF Ratio	2.79	2.79	-	-	-	-
Net Debt / Equity Ratio	-0.48	-0.48	-0.63	-0.58	-0.54	-1.26
Net Debt / EBITDA Ratio	139.56	139.56	6.18	5.07	4.22	-5.30
Net Debt / FCF Ratio	-7.98	-7.98	37.41	62.26	4.64	-10.30
Asset Turnover	1.79	1.79	1.64	1.53	1.39	1.56
Inventory Turnover	5.19	5.19	5.29	5.48	5.53	6.64
Quick Ratio	1.46	1.46	1.81	1.76	1.68	2.36
Current Ratio	2.28	2.28	2.65	2.60	2.61	3.07
Return on Equity (ROE)	-3.11%	-3.11%	-20.45%	-10.90%	-	-
Return on Assets (ROA)	-1.22%	-1.22%	-4.72%	-5.47%	-6.54%	-17.45%
Return on Capital Employed (ROCE)	-2.80%	-2.80%	-11.90%	-12.90%	-14.00%	-29.90%
Earnings Yield	-4.85%	-3.89%	-60.73%	-9.32%	-20.51%	-
FCF Yield	10.01%	8.03%	-4.59%	-0.79%	-1.85%	-
Buyback Yield / Dilution	1.81%	1.81%	1.21%	-59.17%	-76.33%	-87.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.